{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:20Z","timestamp":1790050700474,"version":"4.0.1"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The Epstein-Barr virus (EBV) nuclear antigen EBNA1 is the only viral protein detectably expressed in virus genome-positive Burkitt\u2019s lymphoma (BL); recent work has suggested that viral strains with particular EBNA1 sequence changes are preferentially associated with this tumor and that, within a patient, the tumor-associated variant may have arisen de novo as a rare mutant of the dominant preexisting EBV strain (K. Bhatia, A. Raj, M. J. Gutierrez, J. G. Judde, G. Spangler, H. Venkatesh, and I. T. Magrath, Oncogene 13:177\u2013181, 1996). In the present work we first study 12 BL patients and show that the virus strain in the tumor is identical in EBNA1 sequence and that it is matched at several other polymorphic loci to the dominant strain rescued in vitro from the patient\u2019s normal circulating B cells. We then analyze BL-associated virus strains from three different geographic areas (East Africa, Europe, and New Guinea) alongside virus isolates from geographically matched control donors by using sequence changes in two separate regions of the EBNA1 gene (N-terminal codons 1 to 60 and C-terminal codons 460 to 510) to identify the EBNA1 subtype of each virus. Different geographic areas displayed different spectra of EBNA1 subtypes, with only limited overlap between them; even type 2 virus strains, which tended to be more homogeneous than their type 1 counterparts, showed geographic differences at the EBNA1 locus. Most importantly, within any one area the EBNA1 subtypes associated with BL were also found to be prevalent in the general population. We therefore find no evidence that Burkitt lymphomagenesis involves a selection for EBV strains with particular EBNA1 sequence changes.<\/jats:p>","DOI":"10.1128\/jvi.73.2.965-975.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T13:22:48Z","timestamp":1577798568000},"page":"965-975","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":79,"title":["Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt\u2019s Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas"],"prefix":"10.1128","volume":"73","author":[{"given":"G.","family":"Habeshaw","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Pathology1 and"},{"name":"<!--label omitted: 2-->CRC Institute for Cancer Studies,2 University of Birmingham, Edgbaston, Birmingham B15 2TA, United Kingdom, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q. Y.","family":"Yao","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->CRC Institute for Cancer Studies,2 University of Birmingham, Edgbaston, Birmingham B15 2TA, United Kingdom, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"Bell","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->CRC Institute for Cancer Studies,2 University of Birmingham, Edgbaston, Birmingham B15 2TA, United Kingdom, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Morton","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Kuluva Church of Uganda Hospital, Arua, Uganda3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Rickinson","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->CRC Institute for Cancer Studies,2 University of Birmingham, Edgbaston, Birmingham B15 2TA, United Kingdom, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)91202-6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-1-95"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.3.1466-1478.1991"},{"key":"e_1_3_2_5_2","first-page":"177","article-title":"Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas","volume":"13","author":"Bhatia K.","year":"1996","unstructured":"Bhatia K. Raj A. Gutierrez M. I. Judde J.-G. Spangler G. Venkatesh H. Magrath I. T. Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas.Oncogene 13 1996 177 181","journal-title":"Oncogene"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81056-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90232-5"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980717)77:2<205::AID-IJC6>3.0.CO;2-U"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-1-139"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.23.7632"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1297"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-76-4-779"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-1-85"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-7-1481"},{"key":"e_1_3_2_15_2","unstructured":"Griffiths M. and A. B. Rickinson. Unpublished data."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-7-1663"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.2.600.414k33_600_606"},{"key":"e_1_3_2_18_2","unstructured":"Habeshaw G. and A. B. Rickinson. Unpublished observations."},{"key":"e_1_3_2_19_2","first-page":"1575","article-title":"Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1","volume":"8","author":"Hu L. F.","year":"1993","unstructured":"Hu L. F. Chen F. Zheng X. Ernberg I. Cao S.-L. Christensson B. Klein G. Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1.Oncogene 8 1993 1575 1583","journal-title":"Oncogene"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3491.bloodjournal8893491"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8340-8346.1997"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.10.2937.2937"},{"key":"e_1_3_2_23_2","first-page":"2129","article-title":"Effect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus","volume":"12","author":"Li S.-M.","year":"1996","unstructured":"Li S.-M. Chang Y.-S. Liu S.-T. Effect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus.Oncogene 12 1996 2129 2135","journal-title":"Oncogene"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910520203"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90754-Y"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60470-4"},{"key":"e_1_3_2_27_2","unstructured":"Midgley R. and A. B. Rickinson. Unpublished observations."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-10-2729"},{"key":"e_1_3_2_29_2","first-page":"933","article-title":"Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure","volume":"39","author":"Pope J. H.","year":"1967","unstructured":"Pope J. H. Achong B. G. Epstein M. A. Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure.J. Natl. Cancer Inst. 39 1967 933 945","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_3_2_30_2","unstructured":"Rickinson\nA. B.\nKieff\nE.\nEpstein-Barr virus\nFields virology.\nFields\nB. N.\nKnipe\nD. M.\nHowley\nP. M.\n1996\n2397\n2446\nLippincott-Raven\nPhiladelphia Pa"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.61.5.1310-1317.1987"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/77.3.681"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910350404"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1987.tb02568.x"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.9.4084-4092.1990"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.1.323.323_323_330"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.4.1579.bloodjournal8741579"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.9.6069-6073.1994"},{"key":"e_1_3_2_39_2","first-page":"1545","article-title":"Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumors","volume":"10","author":"Snudden D. K.","year":"1995","unstructured":"Snudden D. K. Smith P. R. Lai D. Ng M. H. Griffin B. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumors.Oncogene 10 1995 1545 1552","journal-title":"Oncogene"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.6.2644-2649.1989"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00674.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1183"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.5.4352-4363.1998"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910430115"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-7-1579"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.8.4884-4894.1996"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-68-11-2853"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.73.2.965-975.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.73.2.965-975.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T22:20:51Z","timestamp":1646432451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.73.2.965-975.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1128\/JVI.73.2.965-975.1999"],"URL":"https:\/\/doi.org\/10.1128\/jvi.73.2.965-975.1999","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]},"assertion":[{"value":"1998-08-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}